Literature DB >> 6407020

Macrophage activation: priming activity from a T-cell hybridoma is attributable to interferon-gamma.

J L Pace, S W Russell, R D Schreiber, A Altman, D H Katz.   

Abstract

Antiviral and macrophage-priming activities in the supernatant medium of a subclone of a concanavalin A-stimulated mouse T-cell hybridoma were investigated. The two activities were associated with a molecular weight of approximately 50,000 and could not be separated by various approaches. Both activities were eliminated by a highly specific neutralizing antibody against mouse interferon-gamma, but not by antibody against interferon-alpha and -beta. The ratio of priming to antiviral activity in the hybridoma culture supernate was indistinguishable from the ratio obtained with mouse interferon-gamma prepared by recombinant DNA technology. It was concluded from these data that the priming activity in hybridoma culture supernates was attributable to interferon-gamma and that this mediator is one form of the lymphokine macrophage-activating factor. Interferon-gamma was greater than 800 times more efficient at priming mouse macrophages for tumor cell killing than was a mixture of interferon-alpha and -beta. This finding contributes to growing awareness that type II interferon may have greater immunoregulatory potential than type I interferons.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6407020      PMCID: PMC394136          DOI: 10.1073/pnas.80.12.3782

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Immunosuppressive effects of lymphocyte (type II) and leucocyte (type I) interferon on primary antibody responses in vivo and in vitro.

Authors:  J L Virelizier; E L Chan; A C Allison
Journal:  Clin Exp Immunol       Date:  1977-11       Impact factor: 4.330

2.  Interferon: an inducer of macrophage activation by polyanions.

Authors:  R M Schultz; J D Papamatheakis; M A Chirigos
Journal:  Science       Date:  1977-08-12       Impact factor: 47.728

3.  The immunosuppressive effect of type II mouse interferon preparations on antibody production.

Authors:  G Sonnenfeld; A D Mandel; T C Merigan
Journal:  Cell Immunol       Date:  1977-12       Impact factor: 4.868

4.  Similarities among factors that render macrophages tumoricidal in lymphokine and interferon preparations.

Authors:  R M Schultz; M A Chirigos
Journal:  Cancer Res       Date:  1978-04       Impact factor: 12.701

5.  Macrophage tumor killing: influence of the local environment.

Authors:  J B Hibbs; R R Taintor; H A Chapman; J B Weinberg
Journal:  Science       Date:  1977-07-15       Impact factor: 47.728

6.  Detection of endotoxin in human blood and demonstration of an inhibitor.

Authors:  J Levin; P A Tomasulo; R S Oser
Journal:  J Lab Clin Med       Date:  1970-06

7.  Macrophage activation for tumor cytotoxicity: development of macrophage cytotoxic activity requires completion of a sequence of short-lived intermediary reactions.

Authors:  L P Ruco; M S Meltzer
Journal:  J Immunol       Date:  1978-11       Impact factor: 5.422

8.  Large-scale production and partial purification of mouse immune interferon.

Authors:  L C Osborne; J A Georgiades; H M Johnson
Journal:  Infect Immun       Date:  1979-01       Impact factor: 3.441

9.  Inhibition of interferon action by vitamin A.

Authors:  J E Blalock; G E Gifford
Journal:  J Gen Virol       Date:  1975-12       Impact factor: 3.891

10.  Fractions of lipopolysaccharide from Escherichia coli O111:B4 prepared by two extraction procedures.

Authors:  D C Morrison; L Leive
Journal:  J Biol Chem       Date:  1975-04-25       Impact factor: 5.157

View more
  52 in total

Review 1.  Cognitive and behavioral consequences of impaired immunoregulation in aging.

Authors:  Angela W Corona; Ashley M Fenn; Jonathan P Godbout
Journal:  J Neuroimmune Pharmacol       Date:  2011-09-20       Impact factor: 4.147

2.  Selective inhibition and augmentation of alternative macrophage activation by progesterone.

Authors:  Fiona M Menzies; Fiona L Henriquez; James Alexander; Craig W Roberts
Journal:  Immunology       Date:  2011-11       Impact factor: 7.397

3.  Synergistic induction of cytotoxicity in macrophages by murine interferon-gamma and biological response modifiers derived from microorganisms.

Authors:  S Nagao; K Sato; Y Osada
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

4.  The experimental and clinical use of immune-modulating drugs in the prophylaxis and treatment of infections.

Authors:  J Drews
Journal:  Infection       Date:  1985       Impact factor: 3.553

5.  A single cell assay for the study of gamma-interferon formation in leprosy patients.

Authors:  J Lindh; U Anderson; S Britton; M De Ley
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

Review 6.  Shared signaling systems in myeloid cell-mediated muscle regeneration.

Authors:  James G Tidball; Kenneth Dorshkind; Michelle Wehling-Henricks
Journal:  Development       Date:  2014-03       Impact factor: 6.868

7.  Relationship between colony-stimulating activity and interferon production during infection.

Authors:  P Egan; C Cheers
Journal:  Immunology       Date:  1990-06       Impact factor: 7.397

8.  Macrophage/monocyte receptor for nonenzymatically glycosylated protein is upregulated by cachectin/tumor necrosis factor.

Authors:  H Vlassara; L Moldawer; B Chan
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

9.  Identification and characterization of a monoclonal antibody to an antigen expressed on activated macrophages.

Authors:  T P Koestler; D Rieman; K Muirhead; R G Greig; G Poste
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

10.  Gamma interferon production in response to homologous and heterologous strain antigens in mice chronically infected with Rickettsia tsutsugamushi.

Authors:  B A Palmer; F M Hetrick; T R Jerrells
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.